Wolfram Syndrome (WS) is a rare neurodegenerative disorder, the patients of which are very early diagnosed with diabetes, optic atrophy and deafness, while their life expectancy is around 30 years due to systemic complications. Two types of WS have been characterized; Type 1 is caused by mutations in the WFS1 gene encoding the ER-localized protein Wolframin, while Type 2 is caused by mutations in the Cisd2 gene. Cisd2 gene encodes a mitochondrial iron-sulfur cluster (ISC) binding protein which belongs to the NEET protein family. Importantly, it is not well understood how loss of the particular ISC binding protein leads to WS pathophysiology in humans. The C. elegans gene
cisd-1 (W02B12.15) encodes a functional homolog of the mammalian NEET protein CISD2, based on sequence analysis and the presence of the conserved domain CDGSH for binding to ISCs. Downregulation of
cisd-1 through RNAi recapitulates key features of CISD2 loss, associated with WS type 2, including short life expectancy and enhanced neurodegeneration. Based on our findings, CISD-1 exerts differential effects on longevity and healthspan, through its involvement in both the intrinsic apoptosis pathway and the autophagic process. The CISD-1- dependent effects on apoptosis and autophagy seem to be affected by intracellular iron levels, suggesting that CISD-1 deficiency may disturb intracellular iron homeostasis. Our work will facilitate the elucidation of the molecular mechanisms underlying WS pathogenesis and provide critical insights towards the development of effective therapeutic strategies.